{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T03:11:20Z","timestamp":1793070680151,"version":"4.5.0"},"reference-count":83,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T00:00:00Z","timestamp":1626393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000361","name":"Diabetes UK","doi-asserted-by":"publisher","award":["16\/0005537"],"award-info":[{"award-number":["16\/0005537"]}],"id":[{"id":"10.13039\/501100000361","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Blood\u2013retinal barrier (BRB) dysfunction underlies macular oedema in many sight-threatening conditions, including diabetic macular oedema, neovascular age-related macular degeneration and uveoretinitis. Inflammation plays an important role in BRB dysfunction. This study aimed to understand the role of the inflammatory cytokine IL-17A in BRB dysfunction and the mechanism involved. Human retinal pigment epithelial (RPE) cell line ARPE19 and murine brain endothelial line bEnd.3 were cultured on transwell membranes to model the outer BRB and inner BRB, respectively. IL-17A treatment (3 days in bEnd.3 cells and 6 days in ARPE19 cells) disrupted the distribution of claudin-5 in bEnd.3 cells and ZO-1 in ARPE19 cells, reduced the transepithelial\/transendothelial electrical resistance (TEER) and increased permeability to FITC-tracers in vitro. Intravitreal (20 ng\/1 \u03bcL\/eye) or intravenous (20 ng\/g) injection of recombinant IL-17A induced retinal albumin leakage within 48 h in C57BL\/6J mice. Mechanistically, IL-17A induced Janus kinase 1 (JAK1) phosphorylation in bEnd.3 but not ARPE19 cells. Blocking JAK1 with Tofacitinib prevented IL-17A-mediated claudin-5 dysmorphia in bEnd.3 cells and reduced albumin leakage in IL-17A-treated mice. Our results suggest that IL-17A can damage the BRB through the activating the JAK1 signaling pathway, and targeting this pathway may be a novel approach to treat inflammation-induced macular oedema.<\/jats:p>","DOI":"10.3390\/biomedicines9070831","type":"journal-article","created":{"date-parts":[[2021,7,18]],"date-time":"2021-07-18T21:16:48Z","timestamp":1626643008000},"page":"831","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["IL-17A Damages the Blood\u2013Retinal Barrier through Activating the Janus Kinase 1 Pathway"],"prefix":"10.3390","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5064-3539","authenticated-orcid":false,"given":"Eimear M.","family":"Byrne","sequence":"first","affiliation":[{"name":"The Wellcome-Wolfson Institute for Experimental Medicine, School of Medicine, Dentistry and Biomedical Sciences, Queen\u2019s University Belfast, Belfast BT9 7BL, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Llori\u00e1n-Salvador","sequence":"additional","affiliation":[{"name":"The Wellcome-Wolfson Institute for Experimental Medicine, School of Medicine, Dentistry and Biomedical Sciences, Queen\u2019s University Belfast, Belfast BT9 7BL, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Tang","sequence":"additional","affiliation":[{"name":"The Wellcome-Wolfson Institute for Experimental Medicine, School of Medicine, Dentistry and Biomedical Sciences, Queen\u2019s University Belfast, Belfast BT9 7BL, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andriana","family":"Margariti","sequence":"additional","affiliation":[{"name":"The Wellcome-Wolfson Institute for Experimental Medicine, School of Medicine, Dentistry and Biomedical Sciences, Queen\u2019s University Belfast, Belfast BT9 7BL, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5661-1386","authenticated-orcid":false,"given":"Mei","family":"Chen","sequence":"additional","affiliation":[{"name":"The Wellcome-Wolfson Institute for Experimental Medicine, School of Medicine, Dentistry and Biomedical Sciences, Queen\u2019s University Belfast, Belfast BT9 7BL, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4000-931X","authenticated-orcid":false,"given":"Heping","family":"Xu","sequence":"additional","affiliation":[{"name":"The Wellcome-Wolfson Institute for Experimental Medicine, School of Medicine, Dentistry and Biomedical Sciences, Queen\u2019s University Belfast, Belfast BT9 7BL, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,7,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.survophthal.2008.10.001","article-title":"Diabetic Macular Edema: Pathogenesis and Treatment","volume":"54","author":"Bhagat","year":"2009","journal-title":"Surv. Ophthalmol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.4103\/1673-5374.276332","article-title":"Inner blood-retina barrier involvement in dry age-related macular degeneration (AMD) pathology","volume":"15","author":"Hudson","year":"2020","journal-title":"Neural Regen. Res."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1097\/CM9.0000000000001015","article-title":"Blood-retinal barrier as a converging pivot in understanding the initiation and development of retinal diseases","volume":"133","author":"Yang","year":"2020","journal-title":"Chin. Med. J."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1167\/iovs.01-1202","article-title":"Leukocyte trafficking in experimental autoimmune uveitis: Breakdown of blood-retinal barrier and upregulation of cellular adhesion molecules","volume":"44","author":"Xu","year":"2003","journal-title":"Investig. Opthalmol. Vis. Sci."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/eye.2012.265","article-title":"Bowman lecture on the role of inflammation in degenerative disease of the eye","volume":"27","author":"Forrester","year":"2013","journal-title":"Eye"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1167\/iovs.13-11747","article-title":"Treatment of Acute Posterior Uveitis in a Porcine Model by Injection of Triamcinolone Acetonide into the Suprachoroidal Space Using Microneedles","volume":"54","author":"Gilger","year":"2013","journal-title":"Investig. Opthalmol. Vis. Sci."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.ophtha.2010.02.031","article-title":"Randomized Trial Evaluating Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular Edema","volume":"117","author":"Elman","year":"2010","journal-title":"Ophthalmology"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e002269","DOI":"10.1136\/bmjopen-2012-002269","article-title":"Current treatments in diabetic macular oedema: Systematic review and meta-analysis","volume":"3","author":"Ford","year":"2013","journal-title":"BMJ Open"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.2147\/OPTH.S115546","article-title":"Update on corticosteroids for diabetic macular edema","volume":"10","author":"Schwartz","year":"2016","journal-title":"Clin. Ophthalmol."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Castro-Navarro, V., Cervera-Taulet, E., Navarro-Palop, C., Monferrer-Adsuara, C., Hern\u00e1ndez-Bel, L., and Montero-Hern\u00e1ndez, J. (2019). Intravitreal dexamethasone implant Ozurdex\u00ae in na\u00efve and refractory patients with different subtypes of diabetic macular edema. BMC Ophthalmol., 19.","DOI":"10.1186\/s12886-018-1022-9"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/aos.13744","article-title":"Fluocinolone acetonide intravitreal implant (Retisert\u00ae) in the treatment of sight threatening macular oedema of juvenile idiopathic arthritis-related uveitis","volume":"96","author":"Leinonen","year":"2018","journal-title":"Acta Ophthalmol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40135-020-00225-1","article-title":"A New Approach for Diabetic Macular Edema Treatment: Review of clinical practice results with 0.19 mg fluocinolone acetonide intravitreal implant including vitrectomized eyes","volume":"8","author":"Estebainha","year":"2020","journal-title":"Curr. Ophthalmol. Rep."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1080\/14656566.2017.1363182","article-title":"Fluocinolone acetonide for the treatment of diabetic macular edema","volume":"18","author":"Veritti","year":"2017","journal-title":"Expert Opin. Pharmacother."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"67","DOI":"10.5005\/jp-journals-10028-1226","article-title":"Steroid-induced Glaucoma: An Avoidable Irreversible Blindness","volume":"11","author":"Phulke","year":"2017","journal-title":"J. Curr. Glaucoma Prac."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s40123-016-0052-8","article-title":"Elevated Intraocular Pressure After Intravitreal Steroid Injection in Diabetic Macular Edema: Monitoring and Management","volume":"5","author":"Stalmans","year":"2016","journal-title":"Ophthalmol. Ther."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/sj.eye.6701895","article-title":"Corticosteroid-induced glaucoma: A review of the literature","volume":"20","author":"Kersey","year":"2005","journal-title":"Eye"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ophtha.2012.07.038","article-title":"Vascular Endothelial Growth Factor A in Intraocular Vascular Disease","volume":"120","author":"Miller","year":"2013","journal-title":"Ophthalmology"},{"key":"ref_18","first-page":"CD007419","article-title":"Anti-vascular endothelial growth factor for diabetic macular oedema: A network meta-analysis","volume":"10","author":"Virgili","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1007\/s13300-019-0631-5","article-title":"Effect of Intravitreal Anti-Vascular Growth Factor Agents with or Without Macular Photocoagulation on Diabetic Macular Edema: A Systematic Review and Meta-Analysis","volume":"10","author":"Cui","year":"2019","journal-title":"Diabetes Ther."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s40265-017-0704-6","article-title":"Therapeutic Options in Refractory Diabetic Macular Oedema","volume":"77","author":"Shah","year":"2017","journal-title":"Drugs"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e000696","DOI":"10.1136\/bmjophth-2020-000696","article-title":"Treatment choices for diabetic macular oedema: A guideline for when to consider an intravitreal corticosteroid, including adaptations for the COVID-19 era","volume":"6","author":"Downey","year":"2021","journal-title":"BMJ Open Ophthalmol."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Yamada, Y., Takamura, Y., Morioka, M., Gozawa, M., Matsumura, T., and Inatani, M. (2020). Microaneurysm density in residual oedema after anti-vascular endothelial growth factor therapy for diabetic macular oedema. Acta Ophthalmol., in press.","DOI":"10.1111\/aos.14706"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"18316","DOI":"10.1038\/srep18316","article-title":"Sustained intraocular VEGF neutralization results in retinal neurodegeneration in the Ins2Akita diabetic mouse","volume":"5","author":"Hombrebueno","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1167\/iovs.61.11.35","article-title":"VEGF-B Is an Autocrine Gliotrophic Factor for M\u00fcller Cells under Pathologic Conditions","volume":"61","author":"Barabas","year":"2020","journal-title":"Investig. Opthalmology Vis. Sci."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.3389\/fnins.2019.01172","article-title":"Relationships Between Neurodegeneration and Vascular Damage in Diabetic Retinopathy","volume":"13","author":"Rossino","year":"2019","journal-title":"Front. Neurosci."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"8546423","DOI":"10.1155\/2018\/8546423","article-title":"Levels of Inflammatory Cytokines IL-1\u03b2, IL-6, IL-8, IL-17A, and TNF-\u03b1 in Aqueous Humour of Patients with Diabetic Retinopathy","volume":"2018","author":"Feng","year":"2018","journal-title":"J. Diabetes Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1097\/IAE.0b013e3181e095c0","article-title":"Angiogenic and inflammatory markers in the intraocular fluid of eyes with diabetic macular edema and influence of therapy with Bevacizumab","volume":"30","author":"Funk","year":"2010","journal-title":"Retina"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"8137417","DOI":"10.1155\/2019\/8137417","article-title":"Aqueous Humor Cytokine Levels in Diabetic Macular Edema Patients with Cotton-Wool Spots","volume":"2019","author":"Park","year":"2019","journal-title":"J. Diabetes Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3389\/fnagi.2019.00286","article-title":"The Interplay Between Systemic Inflammatory Factors and MicroRNAs in Age-Related Macular Degeneration","volume":"11","author":"Grabowicz","year":"2019","journal-title":"Front. Aging Neurosci."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1136\/bjophthalmol-2017-310284","article-title":"Changes in multiple cytokine concentrations in the aqueous humour of neovascular age-related macular degeneration after 2 months of ranibizumab therapy","volume":"102","author":"Sakamoto","year":"2018","journal-title":"Br. J. Ophthalmol."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Guo, S., Yin, H., Zheng, M., Tang, Y., Lu, B., Chen, X., Fu, Q., Qin, Z., Lyu, D., and Tang, Q. (2019). Cytokine profiling reveals increased serum inflammatory cytokines in idiopathic choroidal neovascularization. BMC Ophthalmol., 19.","DOI":"10.1186\/s12886-019-1101-6"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.immuni.2011.08.001","article-title":"Pivotal Role of Dermal IL-17-Producing \u03b3\u03b4 T Cells in Skin Inflammation","volume":"35","author":"Cai","year":"2011","journal-title":"Immunity"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s41038-019-0177-9","article-title":"Neutralization of interleukin-17A alleviates burn-induced intestinal barrier disruption via reducing pro-inflammatory cytokines in a mouse model","volume":"7","author":"Song","year":"2019","journal-title":"Burn. Trauma"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jneuroim.2019.04.011","article-title":"IL-17A is associated with the breakdown of the blood-brain barrier in relapsing-remitting multiple sclerosis","volume":"332","author":"Setiadi","year":"2019","journal-title":"J. Neuroimmunol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"103921","DOI":"10.1016\/j.cellimm.2019.04.009","article-title":"Diabetes-mediated IL-17A enhances retinal inflammation, oxidative stress, and vascular permeability","volume":"341","author":"Sigurdardottir","year":"2019","journal-title":"Cell Immunol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1007\/s00417-014-2842-9","article-title":"Effect of the blockade of the IL-23-Th17-IL-17A pathway on streptozotocin-induced diabetic retinopathy in rats","volume":"253","author":"Xu","year":"2015","journal-title":"Graefe\u2019s Arch. Clin. Exp. Ophthalmol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1159\/000460514","article-title":"Blocking IL-17A Alleviates Diabetic Retinopathy in Rodents","volume":"41","author":"Qiu","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"e280","DOI":"10.1038\/emm.2016.117","article-title":"IL-17A exacerbates diabetic retinopathy by impairing M\u00fcller cell function via Act1 signaling","volume":"48","author":"Qiu","year":"2016","journal-title":"Exp. Mol. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1007\/s10753-014-9973-3","article-title":"Genetic Variants of Interleukin 17A Are Functionally Associated with Increased Risk of Age-Related Macular Degeneration","volume":"38","author":"Zhang","year":"2014","journal-title":"Inflammation"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/nri3459-c1","article-title":"A role for IL-17 in age-related macular degeneration","volume":"13","author":"Shin","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1007\/s00417-020-04649-0","article-title":"Regulatory T cells and IL-17A levels in noninfectious uveitis","volume":"258","author":"Guedes","year":"2020","journal-title":"Graefe\u2019s Arch. Clin. Exp. Ophthalmol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"434","DOI":"10.3109\/09273948.2013.815786","article-title":"Elevated Serum Levels of Interleukin-17A in Uveitis Patients","volume":"21","author":"Jawad","year":"2013","journal-title":"Ocul. Immunol. Inflamm."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"R18","DOI":"10.1186\/ar3697","article-title":"Neutralization of IL-17 ameliorates uveitis but damages photoreceptors in a murine model of spondyloarthritis","volume":"14","author":"Kezic","year":"2012","journal-title":"Arthritis Res. Ther."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1177\/0300060516672369","article-title":"Th17 cell frequency and IL-17A concentrations in peripheral blood mononuclear cells and vitreous fluid from patients with diabetic retinopathy","volume":"44","author":"Chen","year":"2016","journal-title":"J. Int. Med. Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/intimm\/dxm135","article-title":"Differential roles for IFN- and IL-17 in experimental autoimmune uveoretinitis","volume":"20","author":"Yoshimura","year":"2008","journal-title":"Int. Immunol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/1479-5876-9-111","article-title":"Complement component C5a Promotes Expression of IL-22 and IL-17 from Human T cells and its Implication in Age-related Macular Degeneration","volume":"9","author":"Liu","year":"2011","journal-title":"J. Transl. Med."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Ardeljan, D., Wang, Y., Park, S., Shen, D., Chu, X.K., Yu, C.-R., Abu-Asab, M., Tuo, J., Eberhart, C.G., and Olsen, T.W. (2014). Interleukin-17 Retinotoxicity Is Prevented by Gene Transfer of a Soluble Interleukin-17 Receptor Acting as a Cytokine Blocker: Implications for Age-Related Macular Degeneration. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0095900"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Chen, Y., Yang, P., Li, F., and Kijlstra, A. (2011). The Effects of Th17 Cytokines on the Inflammatory Mediator Production and Barrier Function of ARPE-19 Cells. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0018139"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1096\/fj.09-141978","article-title":"Cellular mechanisms of IL-17-induced blood-brain barrier disruption","volume":"24","author":"Huppert","year":"2009","journal-title":"FASEB J."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1248\/bpb.b12-00915","article-title":"Paracellular Barrier and Tight Junction Protein Expression in the Immortalized Brain Endothelial Cell Lines bEND.3, bEND.5 and Mouse Brain Endothelial Cell 4","volume":"36","author":"Watanabe","year":"2013","journal-title":"Biol. Pharm. Bull."},{"key":"ref_51","first-page":"318","article-title":"The mechanism of action of tofacitinib\u2014An oral Janus kinase inhibitor for the treatment of rheumatoid arthritis","volume":"34","author":"Hodge","year":"2016","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"G155","DOI":"10.1152\/ajpgi.00311.2015","article-title":"JAK inhibition using tofacitinib for inflammatory bowel disease treatment: A hub for multiple inflammatory cytokines","volume":"310","author":"Danese","year":"2016","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1056\/NEJMoa1112168","article-title":"Tofacitinib, an Oral Janus Kinase Inhibitor, in Active Ulcerative Colitis","volume":"367","author":"Sandborn","year":"2012","journal-title":"New Engl. J. Med."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.3389\/fimmu.2018.01323","article-title":"The Interleukin-23\/Interleukin-17 Axis Links Adaptive and Innate Immunity in Psoriasis","volume":"9","author":"Erpenbeck","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Bunte, K., and Beikler, T. (2019). Th17 Cells and the IL-23\/IL-17 Axis in the Pathogenesis of Periodontitis and Immune-Mediated Inflammatory Diseases. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20143394"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1172\/JCI28508","article-title":"The IL-23\/IL-17 axis in inflammation","volume":"116","author":"Iwakura","year":"2006","journal-title":"J. Clin. Investig."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1080\/02713680902741696","article-title":"Suppression of Experimental Autoimmune Uveoretinitis by Anti-IL-17 Antibody","volume":"34","author":"Zhang","year":"2009","journal-title":"Curr. Eye Res."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1172\/JCI38702","article-title":"IL-17 produced by neutrophils regulates IFN-\u03b3\u2013mediated neutrophil migration in mouse kidney ischemia-reperfusion injury","volume":"120","author":"Li","year":"2010","journal-title":"J. Clin. Investig."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"3966","DOI":"10.1128\/IAI.05493-11","article-title":"Neutrophils Produce Interleukin 17A (IL-17A) in a Dectin-1- and IL-23-Dependent Manner during Invasive Fungal Infection","volume":"79","author":"Werner","year":"2011","journal-title":"Infect. Immun."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Katayama, M., Ohmura, K., Yukawa, N., Terao, C., Hashimoto, M., Yoshifuji, H., Kawabata, D., Fujii, T., Iwakura, Y., and Mimori, T. (2013). Neutrophils Are Essential as A Source Of Il-17 In The Effector Phase Of Arthritis. PLoS ONE, 8.","DOI":"10.1371\/annotation\/5fedb3bf-c9c2-4862-9ad5-23c8ae484ad5"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/imm.12993","article-title":"Interleukin-17-producing \u03b3\u03b4 T (\u03b3\u03b417) cells in inflammatory diseases","volume":"155","author":"Akitsu","year":"2018","journal-title":"Immunology"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/eji.200839120","article-title":"IL-17-producing \u03b3\u03b4 T cells","volume":"39","author":"Roark","year":"2009","journal-title":"Eur. J. Immunol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"947","DOI":"10.3389\/fimmu.2020.00947","article-title":"Interleukin-17 in Chronic Inflammatory Neurological Diseases","volume":"11","author":"Milovanovic","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"628","DOI":"10.4103\/0301-4738.194339","article-title":"Roles of interleukin-17 in uveitis","volume":"64","author":"Guedes","year":"2016","journal-title":"Indian J. Ophthalmol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1159\/000484907","article-title":"Increased Th1\/Th17 Responses Contribute to Low-Grade Inflammation in Age-Related Macular Degeneration","volume":"44","author":"Chen","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/IIO.0000000000000073","article-title":"Inflammatory Mechanisms of Age-related Macular Degeneration","volume":"55","author":"Knickelbein","year":"2015","journal-title":"Int. Ophthalmol. Clin."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/978-1-4614-3209-8_25","article-title":"Molecular pathology of macrophages and interleukin-17 in age-related macular degeneration","volume":"801","author":"Chan","year":"2014","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1620\/tjem.247.87","article-title":"Interleukin-17: The Role for Pathological Angiogenesis in Ocular Neovascular Diseases","volume":"247","author":"Li","year":"2019","journal-title":"Tohoku J. Exp. Med."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/imm.12512","article-title":"Interleukin-17A deficiency ameliorates streptozotocin-induced diabetes","volume":"146","author":"Tong","year":"2015","journal-title":"Immunology"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"33","DOI":"10.4103\/0301-4738.151464","article-title":"Proliferative and inflammatory factors in the vitreous of patients with proliferative diabetic retinopathy","volume":"63","author":"Trunov","year":"2015","journal-title":"Indian J. Ophthalmol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"41779","DOI":"10.1038\/srep41779","article-title":"IL-17 induces reactive astrocytes and up-regulation of vascular endothelial growth factor (VEGF) through JAK\/STAT signaling","volume":"7","author":"You","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jbspin.2016.05.014","article-title":"Interleukin-17 upregulates vascular endothelial growth factor by activating the JAK\/STAT pathway in nucleus pulposus cells","volume":"84","author":"Hu","year":"2017","journal-title":"Jt. Bone Spine"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1002\/jcp.25575","article-title":"Endothelial STAT3 Activation Increases Vascular Leakage Through Downregulating Tight Junction Proteins: Implications for Diabetic Retinopathy","volume":"232","author":"Yun","year":"2017","journal-title":"J. Cell. Physiol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12974-019-1533-1","article-title":"STAT3 activation in circulating myeloid-derived cells contributes to retinal microvascular dysfunction in diabetes","volume":"16","author":"Chen","year":"2019","journal-title":"J. Neuroinflammation"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"412","DOI":"10.2174\/1566524016666160324130031","article-title":"STAT3 Activation in Circulating Monocytes Contributes to Neovascular Age-Related Macular Degeneration","volume":"16","author":"Chen","year":"2016","journal-title":"Curr. Mol. Med."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Li, X., Cai, Y., Wang, Y.-S., Shi, Y.-Y., Hou, W., Xu, C.-S., Wang, H.-Y., Ye, Z., Yao, L.-B., and Zhang, J. (2012). Hyperglycaemia Exacerbates Choroidal Neovascularisation in Mice via the Oxidative Stress-Induced Activation of STAT3 Signalling in RPE Cells. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0047600"},{"key":"ref_77","first-page":"3206","article-title":"SOCS3 deletion in myeloid cells worsens retinal inflammation and increases angiogenesis in experimental autoimmune uveoretinitis","volume":"56","author":"Zhao","year":"2015","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.ajpath.2017.12.021","article-title":"Cytokine Signaling Protein 3 Deficiency in Myeloid Cells Promotes Retinal Degeneration and Angiogenesis through Arginase-1 Up-Regulation in Experimental Autoimmune Uveoretinitis","volume":"188","author":"Chen","year":"2018","journal-title":"Am. J. Pathol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s10067-019-04875-w","article-title":"JAK inhibitors in refractory juvenile idiopathic arthritis-associated uveitis","volume":"39","author":"Miserocchi","year":"2020","journal-title":"Clin. Rheumatol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ajoc.2018.12.001","article-title":"Tofacitinib for refractory uveitis and scleritis","volume":"13","author":"Paley","year":"2019","journal-title":"Am. J. Ophthalmol. Case Rep."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/ibd\/izz266","article-title":"The JAK-Inhibitor Tofacitinib Rescues Human Intestinal Epithelial Cells and Colonoids from Cytokine-Induced Barrier Dysfunction","volume":"26","author":"Krishnan","year":"2020","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.4049\/jimmunol.1600138","article-title":"IL-17 Promotes Neutrophil-Mediated Immunity by Activating Microvascular Pericytes and Not Endothelium","volume":"197","author":"Liu","year":"2016","journal-title":"J. Immunol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1016\/j.ajpath.2017.04.008","article-title":"Tumor Necrosis Factor-\u03b1 and IL-17A Activation Induces Pericyte-Mediated Basement Membrane Remodeling in Human Neutrophilic Dermatoses","volume":"187","author":"Lauridsen","year":"2017","journal-title":"Am. J. Pathol."}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/9\/7\/831\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:31:00Z","timestamp":1760164260000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/9\/7\/831"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,16]]},"references-count":83,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2021,7]]}},"alternative-id":["biomedicines9070831"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines9070831","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,16]]}}}